Pulmatrix, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of Pulmatrix, Inc.'s 2022 Annual Meeting of Stockholders held on June 15, 2022. The company is incorporated in Delaware and trades on The NASDAQ Stock Market LLC under the symbol "PULM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 1,490,945 shares were present in person or by proxy, representing 44.02% of outstanding shares entitled to vote. The following matters were approved:
- Election of Directors: Two Class II directors were elected to serve until the 2025 annual meeting.
- Teofilo Raad: 422,137 votes For; 178,197 votes Withheld/Abstained.
- Richard Batycky, Ph.D.: 448,559 votes For; 151,775 votes Withheld/Abstained.
- Ratification of Auditors: Marcum LLP was ratified as the independent registered public accounting firm for the 2022 fiscal year.
- 1,378,659 votes For; 97,469 votes Against; 14,817 votes Withheld/Abstained.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. For further details on the proposals, the filing references the definitive proxy statement filed on April 29, 2022.
Investor Verification Checklist
- Verify the final voting results for the election of Teofilo Raad and Richard Batycky, Ph.D.
- Confirm the ratification of Marcum LLP as the independent auditor for fiscal year 2022.
- Review the definitive proxy statement filed on April 29, 2022, for detailed background on the proposals.
- Note that 890,611 broker non-votes were recorded for the director elections.